Ridge Biotechnologies
Palo Alto
About Ridge Biotechnologies
Ridge Bio platform uses proprietary machine learning models built on massive cell-free datasets to design precision enzymes
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $25.0M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: ridgebio.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ridge-biotechnologies-22519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.